pxkkd3s1 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Olagnier%2C_David%3B_Alain%2C_Tommy>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.cytogfr.2020.10.009>
?:doi	10.1016/j.cytogfr.2020.10.009
?:journal	Cytokine_Growth_Factor_Rev
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/4ecfa334b383e1694f1919354dc98d57c36b3f12.json
?:pmc_json_files	document_parses/pmc_json/PMC7610094.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7610094>
?:pmid	<https://research.tib.eu/covid-19/entity/33183956.0>
?:pmid	33183956.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/4ecfa334b383e1694f1919354dc98d57c36b3f12>
?:source	Elsevier; Medline; PMC
?:title	Oncolytic Viral Immunotherapy in the Time of COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-04

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/pxkkd3s1>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/pxkkd3s1>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all